Related Experiment Videos
Chronic, treatment-resistant depression and right fronto-striatal atrophy
P J Shah1, M F Glabus, G M Goodwin
1Department of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Morningside Park, Edinburgh EH10 5HF, Scotland, UK.
Summary
Treatment-resistant depression (TRD) is linked to structural brain changes, specifically right fronto-striatal atrophy. This atrophy correlates with illness severity and cumulative electroconvulsive therapy, suggesting an acquired deficit in TRD patients.
Area of Science:
- Neuroimaging
- Neurobiology
- Psychiatry
Background:
- Treatment-resistant depression (TRD) affects many individuals, yet its underlying neurobiology remains unclear.
- Previous studies suggest fronto-striatal structural brain alterations in depression, but their link to treatment resistance and chronicity is not well-established.
Purpose of the Study:
- To investigate the neurobiological basis of TRD by examining structural brain changes.
- To determine if fronto-striatal structural differences are associated with treatment resistance and illness severity in depression.
Main Methods:
- Magnetic resonance imaging (MRI) was used to compare brain structures in 20 TRD patients, 20 recovered patients, and 20 healthy controls.
- Voxel-based analysis (VBA) and conventional volumetric analysis were employed to assess brain images.
- Clinical data, including illness duration and severity, were correlated with MRI findings using VBA.
Main Results:
- The TRD group showed significant right fronto-striatal atrophy and subtle left hippocampal MRI changes via VBA.
- Volumetric analysis confirmed the atrophy, which correlated with the number of electroconvulsive therapy (ECT) treatments received.
- These findings suggest an acquired neurobiological deficit in patients with TRD.
Conclusions:
- This study provides the first evidence of fronto-striatal atrophy in patients with treatment-resistant depression and poor outcomes.
- The degree of atrophy is more pronounced in individuals with more severe illness, highlighting a potential biomarker for depression severity.